|
The complaint device has been discarded.As a result, no product failure analysis can be conducted, and device malfunction cannot be confirmed.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Reason for device explant and/or reoperation: right breast hematoma, breast mass.Explantation was performed to treat bilateral capsular contracture.Mentor is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which mentor has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, mentor, or its employees that the report constitutes an admission that the device, mentor, or its employees caused or contributed to the potential event described in this report.If certain information is unknown, not available or does not apply, the section/field of the form is left blank.Manufacturer¿s reference number: (b)(4).
|
|
It was reported that a 38-year-old caucasian female patient who underwent a primary breast augmentation procedure with mentor memorygel xtra breast implant 235cc gel breast prostheses developed baker grade iii capsular contracture in both of her breasts post implantation.Additionally, the patient underwent evacuation of a right breast hematoma.The patient also underwent a left purse string mastopexy and excisional biopsy of a right breast benign infra-areolar mass in may 2022.To treat the bilateral capsular contracture, the patient underwent bilateral explantation and replacement with natrelle gel breast prostheses on (b)(6) 2023.This medwatch report is for the patient¿s right breast prosthesis.
|